Jessica Hagen
Cuban tells MobiHealthNews that MCCPDC is working on adding partnerships with PBMs that "share our mission of cost-plus pricing, transparency and no rebates."
The investment, a mix of equity and debt, will go toward company growth and product development.
The Series D funding round announcement follows CEO Eren Bali's Twitter post on Friday that reported a second round of layoffs affecting more than 200 people.
The funds will help expand the company's deployment of its in-home kidney and polychronic care delivery model and its clinical services.
The company let go of over 200 people in its second round of layoffs in the past year and plans to shift its focus to its primary care and urgent care services.
The investment will help expand the telepsychiatry platform's reach.
The company’s Intelligent Dialysis Assistant allows patients to undergo dialysis outside a clinic while being remotely supervised by a healthcare professional.
Cancer care platform Onc.AI, data analytics company Porter and virtual care platform KeyCare also closed funding rounds.
U-Scan, an in-home biomarker analysis platform, sits within the toilet bowl to analyze the user's urine.
Spero Health will widen its use of Pear's reSET and reSET-O prescription digital therapeutics from 14 clinics in Kentucky to 99 locations in five other states.